JP2005289938A5 - - Google Patents

Download PDF

Info

Publication number
JP2005289938A5
JP2005289938A5 JP2004110487A JP2004110487A JP2005289938A5 JP 2005289938 A5 JP2005289938 A5 JP 2005289938A5 JP 2004110487 A JP2004110487 A JP 2004110487A JP 2004110487 A JP2004110487 A JP 2004110487A JP 2005289938 A5 JP2005289938 A5 JP 2005289938A5
Authority
JP
Japan
Prior art keywords
parts
weight
mass
mass parts
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004110487A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005289938A (ja
JP4836044B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2004110487A priority Critical patent/JP4836044B2/ja
Priority claimed from JP2004110487A external-priority patent/JP4836044B2/ja
Publication of JP2005289938A publication Critical patent/JP2005289938A/ja
Publication of JP2005289938A5 publication Critical patent/JP2005289938A5/ja
Application granted granted Critical
Publication of JP4836044B2 publication Critical patent/JP4836044B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004110487A 2004-04-02 2004-04-02 経口アミノ酸ニキビ治療剤 Expired - Fee Related JP4836044B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004110487A JP4836044B2 (ja) 2004-04-02 2004-04-02 経口アミノ酸ニキビ治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004110487A JP4836044B2 (ja) 2004-04-02 2004-04-02 経口アミノ酸ニキビ治療剤

Publications (3)

Publication Number Publication Date
JP2005289938A JP2005289938A (ja) 2005-10-20
JP2005289938A5 true JP2005289938A5 (cg-RX-API-DMAC7.html) 2007-05-31
JP4836044B2 JP4836044B2 (ja) 2011-12-14

Family

ID=35323287

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004110487A Expired - Fee Related JP4836044B2 (ja) 2004-04-02 2004-04-02 経口アミノ酸ニキビ治療剤

Country Status (1)

Country Link
JP (1) JP4836044B2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4218751A3 (en) * 2016-02-23 2024-03-06 Cancer Research Technology Ltd Dietary product devoid of at least two non essential amino acid
CN116075238B (zh) 2020-06-03 2025-11-04 菲思治疗公司 用于个体化治疗方法的制剂
JP2023528930A (ja) 2020-06-04 2023-07-06 フェス・セラピューティクス,インコーポレーテッド がんを処置する個別化された方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616617A (en) * 1995-11-27 1997-04-01 Van Moerkerken; Arthur Face pimples prevention method and compositions
ATE456302T1 (de) * 1997-09-17 2010-02-15 Strategic Science & Technologi Verabreichung von arginin zur erwärmung von kaltem/kühlem gewebe
JPH11269034A (ja) * 1998-03-20 1999-10-05 Shiseido Co Ltd ニキビ改善用皮膚外用剤
FR2778562B1 (fr) * 1998-05-14 2000-08-04 Sephra Composition pharmaceutique, hygienique et/ou cosmetique contenant de l'eau de mer et de l'arginine
JP2001224334A (ja) * 2000-02-16 2001-08-21 Ajinomoto Co Inc アミノ酸含有美容食品
JP3827923B2 (ja) * 2000-06-20 2006-09-27 味の素株式会社 造血および栄養状態改善用アミノ酸組成物
US7338675B2 (en) * 2002-05-10 2008-03-04 Tsi Health Sciences, Inc. Fenugreek seed bio-active compositions and methods for extracting same

Similar Documents

Publication Publication Date Title
WO2008081582A1 (ja) 容器詰飲料
ATE161397T1 (de) Diätetische zusammensetzung für jugendliche
EP1582208A3 (en) An amino acid compositions for promoting collagen synthesis
ATE365212T1 (de) Verfahren zur fermentativen herstellung von l- histidin durch aminochinolin-resistente bakterienstämme der gattung escherichia
IL184027A (en) Trisodium compound [3 - ((1s, 3r) -1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl) propionate (s) - 3-methyl-2-pentanoyl {"2 - (tetrazole) (5-yl) biphenyl-4-ylmethyl} amino) butyrate] The hypanthate hydrate, its pharmaceutical preparations, its method of preparation and its use in the preparation of drugs
ATE557096T1 (de) L-tryptophan produzierendes bakterium und verfahren zur produktion von l-tryptophan
JP2010513259A5 (cg-RX-API-DMAC7.html)
ATE541568T1 (de) Infusionsflüssigkeit zur behandlung der anämie bei dialysepatienten
RU2009126763A (ru) Лечение общих расстройств развития
JP2018529648A5 (cg-RX-API-DMAC7.html)
JP2896192B2 (ja) プライマー組成物
ATE504580T1 (de) Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit
DE602004026514D1 (de) Orale Zusammensetzung aus Naturstoffen zum Erhalt der richtigen Hautfeuchtigkeit
JP2006516141A5 (cg-RX-API-DMAC7.html)
JP2004534073A5 (cg-RX-API-DMAC7.html)
PL377832A1 (pl) Nowy proces syntezy kwasu (2s)-indolino-2-karboksylowego oraz jego zastosowanie do syntezy perindoprilu
RU2010105710A (ru) Мутантная аденилатциклаза, днк, кодирующая ее, бактерия семейства enterobacteriaceae, содержащая указанную днк, и способ получения l-аминокислот
RU2005101110A (ru) Способ получения l-аминокислот с использованием бактерии семейства enterobacteriaceae, в которой разрушен путь биосинтеза гликогена
ATE536342T1 (de) Neue carbamoylglycinderivate
WO2008096846A1 (ja) 安定同位体標識タンパク質合成用組成物及び安定同位体標識タンパク質の製造方法
TW200605798A (en) Non-essential amino acids containing pharmaceutical composition and uses thereof
CA2586239A1 (en) Methods for regulating weight and size of animals with glycine
JP2025515787A5 (cg-RX-API-DMAC7.html)
ES2132021A1 (es) Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas.
CN101120918A (zh) 适用于肝病患者的复方氨基酸注射液组合物